Chris Agbega about the need of investments in NCD prevention and care

The human toll of noncommunicable diseases (NCDs) is unacceptable, inequitable, and increasing. There are 41 million deaths from NCDs each year, and this number is expected to rise to 52 million by 2030. Three-quarters of these deaths, and 85% of NCD ‘premature’ deaths between the ages of 30 and 70, occur in low- and middle-income countries (LMICs). Up to 80% of these diseases can be prevented or delayed into old age through actions.

At the same, noncommunicable diseases is more than a healthcare issue, it is also human-rights issue. Out-of-pocket payments for health expenses push an estimated 100 million people worldwide into extreme poverty every year.

There is a strong and urgent imperative for investment in NCDs. While considering NCD financing it is worth remembering that for every dollar invested in the cost-effective interventions – known as the WHO Best Buys – for noncommunicable disease prevention and care in poorer countries, there will be a return to society of at least $7 in increased employment, productivity and longer life. 

Listen to Chris Agbega, an NCD advocate and a person living with an NCD talking about NCD investments from his own experience.

[NAALARTEY-lqfo]

Hi I am a Ghanaian in UK, I am interested in becoming an advocate for sick cell disease